Thomas R. Fleming
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Public Health, Biostatistics BiologyGoogle:
"Thomas Fleming"Cross-listing: PHTree
Parents
Sign in to add mentor| Grace Lo Yang | grad student | 1976 | University of Maryland | |
| (http://www.math.umd.edu/~gyang1/) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| DeMets DL, Fleming TR. (2020) Achieving Effective Informed Oversight by DMCs in COVID Clinical Trials. Journal of Clinical Epidemiology |
| Bhatnagar V, Hudgens S, Piault-Louis E, et al. (2020) Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019. The Oncologist |
| Dean NE, Gsell PS, Brookmeyer R, et al. (2020) Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. The New England Journal of Medicine. 382: 1366-1369 |
| Fleming TR, DeGruttola V, Donnell D. (2019) Designing & Conducting Trials To Reliably Evaluate HIV Prevention Interventions. Statistical Communications in Infectious Diseases. 11 |
| Giles JT, Sattar N, Gabriel S, et al. (2019) Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial. Arthritis & Rheumatology (Hoboken, N.J.) |
| Fleming TR, Ellenberg SS, DeMets DL. (2018) Data Monitoring Committees: Current issues. Clinical Trials (London, England). 1740774518764855 |
| Fleming TR, DeMets DL, Roe MT, et al. (2017) Data monitoring committees: Promoting best practices to address emerging challenges. Clinical Trials (London, England). 14: 115-123 |
| Fleming TR, Ellenberg SS. (2016) Evaluating interventions for Ebola: The need for randomized trials. Clinical Trials (London, England). 13: 6-9 |
| Odem-Davis K, Fleming TR. (2015) A Simulation Study Evaluating Bio-Creep Risk in Serial Noninferiority Clinical Trials for Preservation of Effect Statistics in Biopharmaceutical Research. 7: 12-24 |
| Fleming TR. (2015) Protecting the confidentiality of interim data: addressing current challenges. Clinical Trials (London, England). 12: 5-11 |